Research Article
Ovarian Cancer Stem Cells with High ROR1 Expression Serve as a New Prophylactic Vaccine for Ovarian Cancer
Figure 4
The levels of IFN-γ, anti-ROR1 antibody, and TGF-β1 as measured by ELISA. (a, c) Serum IFN-γ level in the different vaccinated groups. (b, d) Serum TGF-β1 level in the different vaccinated groups. (e, f) Anti-ROR1 antibody level in the second (serum 1 : 40 dilution) and the third (serum 1 : 320 dilution) immunizations. Data are represented as the (). Statistically significant differences were indicated.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |